« Home | U.S. Biodefense Bill to Be Reintroduced Today » | Drug Trials With a Dose of Doubt - A TIMES INVESTI... » | Work on Pandemic Flu Vaccines Must Start Now, WHO ... » | N.Y. Times Receives Suspicious Mail » | Medical Journal Says It Was Again Misled » | EDITORIAL - Time to end anthrax suit » | Pentagon weighs options in anthrax vaccine suit - ... » | Bio-Weapons: Creating the Next Generation of Anthr... » | THE FDA LOWERS THE BOOM ON CITIZENS' RIGHTS » | Fraunhofer to receive $15 million in state and pri... »

Smallpox Drug Passes First Human Safety Tests

Global Security Newswire

An experimental smallpox drug successfully passed the first round of human safety testing, The Oregonian reported yesterday (see GSN, Jan. 27).

Volunteers given different doses of the drug suffered no significant side effects.

Siga Technologies Inc. is seeking federal approval for a three-week trial of daily dosing, said Chief Financial Officer Thomas Konatich

The publicly owned company has conducted animal studies in two species. One study proved that the smallpox drug protects ground squirrels from lethal does of monkeypox (Joe Rojas-Burke, The Oregonian, July 15).